Biosystems Immunolab
Debrecen · Founded 2020
About Biosystems Immunolab
Biosystems Immunolab uses its protected protein epitome profiling technology platform for the discovery and creation of disease-specific plasma protein epitope panels to provide solutions for the early diagnosis of cancer. They employ several different technologies.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2020)
- Website: https://biosys-ilab.com/
Industries & Categories
Bioinformatics, Biopharma, Biotechnology
Canonical: https://fsome.com/organization/biosystems-immunolab-81933 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.